| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| H Ikegami, S A Spahn, C Prasa. Neuropeptide-dopamine interactions. IV. Effect of thyrotropin-releasing hormone on striatal dopaminergic neurons. Peptides. vol 10. issue 3. 1989-10-20. PMID:2528727. |
in conclusion, these data suggest that in vivo administration of trh may modulate dopaminergic activities by altering, directly or indirectly, dopamine release and reuptake. |
1989-10-20 |
2023-08-11 |
Not clear |
| A Kolta, T A Reade. Modulatory effects of catecholamines on neurons of the rat visual cortex: single-cell iontophoretic studies. Canadian journal of physiology and pharmacology. vol 67. issue 6. 1989-10-20. PMID:2570629. |
the catecholamines noradrenaline and dopamine have been proposed as neuromodulators of cortical neuron excitability, and such a regulation could be mediated by specific adrenergic and dopaminergic receptors. |
1989-10-20 |
2023-08-11 |
rat |
| W D Kerns, E Arena, D G Morga. Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat. The American journal of pathology. vol 135. issue 2. 1989-10-20. PMID:2571297. |
role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat. |
1989-10-20 |
2023-08-11 |
rat |
| W D Kerns, E Arena, D G Morga. Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat. The American journal of pathology. vol 135. issue 2. 1989-10-20. PMID:2571297. |
dopamine, an alpha- and beta-adrenoceptor and dopaminergic agonist, is used clinically, principally as a pressor agent. |
1989-10-20 |
2023-08-11 |
rat |
| W D Kerns, E Arena, D G Morga. Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat. The American journal of pathology. vol 135. issue 2. 1989-10-20. PMID:2571297. |
thus, the induction of splanchnic arterial lesions in the rat by dopamine and fm is caused by stimulation of, and interaction between, alpha-adrenoceptors and dopaminergic da1 receptors. |
1989-10-20 |
2023-08-11 |
rat |
| A J Stoessl, M T Martin-Iverson, T M Barth, C T Dourish, S D Iverse. Effects of ageing on the behavioural responses to dopamine agonists: decreased yawning and locomotion, but increased stereotypy. Brain research. vol 495. issue 1. 1989-10-19. PMID:2570627. |
these findings suggest that (1) the dopamine receptors mediating yawning and stereotypy have different anatomical locations (2) ageing is associated with decreased responsiveness to stimulation of dopamine autoreceptors, consequent upon the loss of dopaminergic nerve terminals, and (3) while the functional response to selective stimulation of postsynaptic d2 receptors decreases with age, the postsynaptic response to a mixed d1/d2 agonist increases. |
1989-10-19 |
2023-08-11 |
rat |
| P A Broderic. Characterizing stearate probes in vitro for the electrochemical detection of dopamine and serotonin. Brain research. vol 495. issue 1. 1989-10-19. PMID:2776030. |
the methodology is relevant to the interpretation of electrochemical signals for dopamine and serotonin in vivo in neuroanatomical substrates, richly innervated by dopaminergic and serotonergic neuronal circuitry. |
1989-10-19 |
2023-08-11 |
Not clear |
| B Moghaddam, B S Bunne. Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: comparison to amphetamine. Synapse (New York, N.Y.). vol 4. issue 2. 1989-10-19. PMID:2781466. |
based on the relatively small increase of extracellular dopamine levels in medial prefrontal cortex by cocaine, it is postulated that dopaminergic innervation of other structures besides medial prefrontal cortex may be involved in maintenance of cocaine self-administration. |
1989-10-19 |
2023-08-11 |
rat |
| E Chung, M T Dvorozniak, M H Van Woert, H C L. Regional distribution of calcium/calmodulin-dependent phosphatase activity of calcineurin in rat brain. Research communications in chemical pathology and pharmacology. vol 64. issue 3. 1989-10-13. PMID:2551001. |
within the striatum, calcineurin activity does not appear to be present in dopaminergic terminals, since lesions of the nigro-striatal dopaminergic pathway (which reduce striatal dopamine levels by 97%) had no effect on calcineurin activity. |
1989-10-13 |
2023-08-11 |
rat |
| R K Carder, D Jackson, H J Morris, R D Lund, M J Zigmon. Dopamine released from mesencephalic transplants restores modulation of striatal acetylcholine release after neonatal 6-hydroxydopamine: an in vitro analysis. Experimental neurology. vol 105. issue 3. 1989-10-10. PMID:2569987. |
we wished to determine whether dopamine released from the transplant also reinstated dopaminergic inhibition of striatal acetylcholine release. |
1989-10-10 |
2023-08-11 |
rat |
| H Haikala, T Leikola-Pelh. Nicotine antagonizes the effects of reserpine on the striatal metabolism of dopamine, 5-hydroxytryptamine and noradrenaline in hypothermic but not in normothermic mice. Naunyn-Schmiedeberg's archives of pharmacology. vol 339. issue 5. 1989-09-29. PMID:2770886. |
the changes in striatal metabolism of dopamine, noradrenaline and 5-hydroxytryptamine (5-ht) we nicotine had temperature dependent effects on the dopamine metabolism which indicates a block of dopaminergic neurons as suggested in our earlier studies. |
1989-09-29 |
2023-08-11 |
mouse |
| S Rose, M Nomoto, E Kelly, G Kilpatrick, P Jenner, C D Marsde. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP. Neuroscience letters. vol 101. issue 3. 1989-09-25. PMID:2505199. |
increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin mptp. |
1989-09-25 |
2023-08-11 |
Not clear |
| B Dean, D L Copolo. Dopamine uptake by platelets is selective, temperature dependent and not influenced by the dopamine-D1 or dopamine-D2 receptor. Life sciences. vol 45. issue 5. 1989-09-25. PMID:2570336. |
the human platelet, which takes up and releases dopamine, has been proposed as a peripheral model for the study of dopaminergic neurons in the central nervous system (cns). |
1989-09-25 |
2023-08-11 |
human |
| M F Suaud-Chagny, M Buda, F G Gono. Pharmacology of electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry. European journal of pharmacology. vol 164. issue 2. 1989-09-20. PMID:2788097. |
dopamine (da) release was evoked by electrical stimulation of the dopaminergic pathway. |
1989-09-20 |
2023-08-11 |
rat |
| M S Lidow, P S Goldman-Rakic, P Rakic, R B Inni. Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride. Proceedings of the National Academy of Sciences of the United States of America. vol 86. issue 16. 1989-09-19. PMID:2548214. |
an apparent involvement of dopamine in the regulation of cognitive functions and the recognition of a widespread dopaminergic innervation of the cortex have focused attention on the identity of cortical dopamine receptors. |
1989-09-19 |
2023-08-11 |
rat |
| M E Wolf, M J Zigmond, G Kapato. Tyrosine hydroxylase content of residual striatal dopamine nerve terminals following 6-hydroxydopamine administration: a flow cytometric study. Journal of neurochemistry. vol 53. issue 3. 1989-09-18. PMID:2569507. |
although the absolute number of dopaminergic synaptosomes was decreased in lesioned animals, those residual dopamine terminals present contained more tyrosine hydroxylase than did dopamine terminals from control rats. |
1989-09-18 |
2023-08-11 |
rat |
| R G Booth, N Castagnoli, H Rollem. Intracerebral microdialysis neurotoxicity studies of quinoline and isoquinoline derivatives related to MPTP/MPP+. Neuroscience letters. vol 100. issue 1-3. 1989-09-15. PMID:2788253. |
the in vivo dopaminergic neurotoxicity of a series of quinoline and isoquinoline derivatives was assessed in rats using an intrastriatal microdialysis technique that measures the release of dopamine. |
1989-09-15 |
2023-08-11 |
human |
| J S Schneider, A Yuwile. GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism. Experimental neurology. vol 105. issue 2. 1989-09-01. PMID:2568945. |
on the basis of these observations, gm1 appears to increase the dopamine content of the striatum by promoting or stimulating regenerative sprouting of dopaminergic terminals and perhaps collateral sprouting from remaining intact fibers in the mptp model of parkinsonism in the young mouse. |
1989-09-01 |
2023-08-11 |
mouse |
| I Wulle, J Schnitze. Distribution and morphology of tyrosine hydroxylase-immunoreactive neurons in the developing mouse retina. Brain research. Developmental brain research. vol 48. issue 1. 1989-08-31. PMID:2568894. |
biochemical measurements of the endogenous catecholamine content showed that at all developmental stages only dopamine was detectable, suggesting that the th-labeled cells represent dopaminergic neurons. |
1989-08-31 |
2023-08-11 |
mouse |
| F J Monsma, D L Brassard, D R Sible. Identification and characterization of D1 and D2 dopamine receptors in cultured neuroblastoma and retinoblastoma clonal cell lines. Brain research. vol 492. issue 1-2. 1989-08-31. PMID:2665904. |
the recent availability of high specific activity radiolabeled dopaminergic antagonists with specificity for dopamine receptor subtypes has allowed us to screen a wide variety of cultured mammalian cell lines for the presence of d1 and d2 dopamine receptors. |
1989-08-31 |
2023-08-11 |
human |